AbbVie is a global, diversified research-based biopharmaceutical company that operates as a single segment dedicated to discovering, developing, manufacturing, and commercializing innovative medicines. It holds leadership positions across immunology, where Skyrizi and Rinvoq have succeeded Humira across rheumatology, dermatology, and gastroenterology indications; oncology, including hematologic and solid tumor therapies; neuroscience, spanning psychiatry, migraine, and Parkinson's disease; and aesthetics, led by Botox and the Juvederm filler line. The company was incorporated in Delaware in 2012 and became independent in January 2013 when Abbott Laboratories distributed AbbVie's stock to its shareholders. Headquartered in North Chicago, Illinois, AbbVie sells its products worldwide, with commercial operations organized by geography and therapeutic area and a global R&D and supply-chain organization supporting the portfolio.

Piotroski F-Score

Beneish M-Score

PE Ratio

Insider Sell

Operating Margin %

Dividend Payout Ratio

Price

PS Ratio

Dividend Yield %

Altman Z-Score

AbbVie Inc